CervoMed (NASDAQ:CRVO – Get Free Report) had its target price lifted by equities research analysts at Canaccord Genuity Group from $12.00 to $21.00 in a report issued on Tuesday,Benzinga reports.
Shares of NYSE:KIM opened at $20.94 on Monday. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.65 and a quick ratio of 3.59. Kimco Realty has a 1-year low of $17.57 and a 1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback